Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-22-053372

Chief Operating Officer sold 3,125 shares at an average $7.26 ($22,685)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
ADAMS R MARK Chief Operating Officer 2022-10-07 Sale −841 $7.61 $6,400 118,927 D
ADAMS R MARK Chief Operating Officer 2022-10-10 Sale −2,284 $7.13 $16,285 116,643 D
Open-market sales · 3,125 sh · avg $7.26 · $22,685
Loading xslF345X03/doc4.xml…